Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential vanilloid subtype 3 (TRPV3) is a non-selective cation channel primarily expressed in keratinocytes and peripheral neurons. It functions as a sensor for innocuous warm temperatures and various chemical stimuli, influencing cellular signaling pathways involved in itch sensation, dermatitis, hair growth regulation, and skin regeneration. It's upregulated during injury or inflammation and considered a potential therapeutic target for treating pain and itch.
Inhibition of TRPV3 channel activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient Receptor Potential Vanilloid Subtype 3 (TRPV3).